SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-21-001081
Filing Date
2021-01-22
Accepted
2021-01-22 16:06:38
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 atos20210114_s3.htm S-3 294872
2 EXHIBIT 5.1 OPINION OF GIBSON, DUNN & CRUTCHER LLP ex_221851.htm EX-5.1 6680
3 EXHIBIT 23.1 AUDITORS' CONSENT ex_221864.htm EX-23.1 3625
4 atos20210114_s3img001.jpg GRAPHIC 6151
5 image01.jpg GRAPHIC 2834
6 image02.jpg GRAPHIC 4644
  Complete submission text file 0001437749-21-001081.txt   325346
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252335 | Film No.: 21545833
SIC: 2834 Pharmaceutical Preparations